Secure your privacy with Surfshark VPN! Go to https://surfshark.com/ticker or use code TICKER at checkout to get 4 extra months for free!
1 extracted signal · 1 resolved · 0 still active
Ticker Symbol: YOUIndependent analyst profile- Source published
- 18 Jul 2025, 19:05 UTC
- Recorded by Tahlil Plus
- 18 May 2026, 20:23 UTC

AI-generated source summary
The analysis presents a bullish outlook on NVDA, highlighting the Trump administration's reapproval of AI chip sales to China, Meta Platforms building a supercluster, and OpenAI launching an AI web browser as key drivers for Nvidia's growth. The Trump administration just reapproved AI chip sales to China with Meta Platforms building an AI supercluster. China accounted for about 13% of revenue for NVIDIA last year and analyst are estimating that around $8 billion of deferred or canceled revenue will be recognized over the next few quarters. This opens a key sales channel, and overall revenues from China could reach 15 to 20 billion dollars by the end of the year, which is around 15% of NVIDIA's total annual revenue. The stock is expected to reach $204 within the next year. A failure point for the analysis is put at 170.
AI-generated summary based on the source content.
Signal outcomes at a glance
Evaluation CompleteSignals in this source
Evidence and evaluation progress
- Original source published
The analyst published the original source item.
- Source recorded by Tahlil Plus
The public source was preserved as the evidence record for this case.
- Market predictions extracted
1 eligible signal linked to this case.
- Outcome tracking started
Tahlil Plus began monitoring the extracted predictions.
- First prediction resolved
The first evaluable outcome in this case reached a terminal result.
- Case evaluation completed
All evaluable predictions in this case reached terminal outcomes.
Ticker Symbol: YOU
Platform-wide history, separate from this source evaluation.
Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.
